SCHEMBL17733151

SCHEMBL17733151

CCOC(=O)c1cc(OC(C)=O)c2cc(OC)ccc2c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
HPGD P15428 5/20 0.49
KDM4E B2RXH2 4/20 0.49
NPSR1 Q6W5P4 1/20 0.47
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 2/20 0.45
LMNA P02545 2/20 0.45
PPARG P37231 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 3/20 0.44
TP53 P04637 4/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
RECQL P46063 1/20 0.43
GAA P10253 2/20 0.43
CYP1A2 P05177 1/20 0.43
ELANE P08246 1/20 0.43
MAOB P27338 2/20 0.42
CA12 O43570 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8510685 0.89 PLA2G2A (0.51) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL17736803 0.88 KDM4E (0.52) ALDH1A1HPGDKDM4ENPSR1KMT2A
SCHEMBL24620800 0.87 HTT (0.48) ALDH1A1HPGDKDM4ENPSR1KMT2A
SCHEMBL9899615 0.82 PLA2G2A (0.49) ALDH1A1HPGDKDM4ETDP1MAPT
SCHEMBL6383895 0.82 BACE1 (0.51) ALDH1A1HPGDKDM4ETDP1SMN1; SMN2
SCHEMBL15247977 0.81 ALDH1A1 (0.43) ALDH1A1HPGDKDM4ENPSR1KMT2A
SCHEMBL6169984 0.80 RAB9A (0.40) ALDH1A1HPGDKDM4ENPSR1KMT2A
SCHEMBL16301294 0.79 DGAT1 (0.46) ALDH1A1HPGDKDM4EKMT2ATDP1
SCHEMBL15452335 0.78 ALDH1A1 (0.39) ALDH1A1HPGDKDM4ENPSR1KMT2A
SCHEMBL25876669 0.78 BACE1 (0.44) ALDH1A1HPGDKDM4ENPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643905-B2 Phenylnaphthol derivatives TOKUYAMA CORPORATION (JP) 2017-05-09 US disclosed
US-20160130203-A1 NOVEL PHENYLNAPHTHOL DERIVATIVES TOKUYAMA CORPORATION (JP) 2016-05-12 US disclosed
EP-3018115-A1 NOVEL PHENYL NAPTHOL DERIVATIVE Tokuyama Corporation (JP) 2016-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130203-A1 NOVEL PHENYLNAPHTHOL DERIVATIVES AHR, ARL1, PAH ALDH1A1 889/4885HPGD 1570/4885KDM4E 3611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.